Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.
Reticare_USA to Exhibit at 2016 International CES, booth #36511, LVCC-SOUTH HALL 4
TAMPA, Fla.–(BUSINESS WIRE)–Reticare the world leader in eye protection from high energy light will show case two new innovative products at CES 2016 — Reticare Glasses and Reticare Glass.
Mycotic Ulcer Treatment Trial II
Status: Active, not recruiting,
Condition Summary: Corneal Ulcer; Eye Infections, Fungal
Uncategorized
Issues with safety of anti-VEGF agents in infants with ROP call for further investigation
VIENNA — Increasing evidence supports the efficacy of anti-VEGF agents in the treatment of retinopathies, but safety concerns remain with their use in infants, requiring further investigation, according to a specialist speaking at the Advanced Retinal Therapy meeting. Focusing on retinopathy of prematurity, Mary Elizabeth Hartnett, MD, said that multiple case series and small trials as well as the BEAT-ROP study found efficacy in reducing intravitreal neovascularization and facilitating physiologic retinal vascular development in some cases.
Small Practices Can Avoid Selling Themselves to Hospitals
(MedPage Today) — Merging practices can be a viable alternative, says Yul Ejnes, MD
A Teaching Hospital Without Medical Students?
(MedPage Today) — F. Perry Wilson examines a study of ERs with and without med students